România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
encepur adulti 1,5 µg/0,5 ml
gsk vaccines gmbh - germania - vaccin impotriva encefalitei de capuse - susp. inj. in seringa preumpluta - 1,5µg/0,5ml - vaccinuri virale vaccinuri contra encefalitei
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
encepur copii 0,75 µg/0,25 ml
gsk vaccines gmbh - germania - vaccin impotriva encefalitei de capuse - susp. inj. in seringa preumpluta - 0,75µg/0,25ml - vaccinuri virale vaccinuri contra encefalitei
Uniunea Europeană -
română -
EMA (European Medicines Agency)
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - febra hemoragica ebola - vaccinuri - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
vaxchora
bavarian nordic a/s - vibrio cholerae, tulpina cvd 103-hgr, live - holeră - vaccinuri - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. acest vaccin ar trebui să fie utilizate în conformitate cu recomandările oficiale.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
imvanex
bavarian nordic a/s - vaccinia modificată ankara - virusul nordic bavarez (mva-bn) - smallpox vaccine; monkeypox virus - alte vaccinuri virale, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 și 5. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
heplisav b
dynavax gmbh - hepatita b antigen de suprafață - hepatita b - vaccinuri - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.
Republica Moldova -
română -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
diphereline 11 25 mg 11,25 mg pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită
ipsen pharma - triptorelinum - pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită - 11,25 mg
Republica Moldova -
română -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
puregon solutie injectabila in cartus 300 ui/0,36 ml
merck sharp&dohme limited - follitropinum beta - solutie injectabila in cartus - 300 ui/0,36 ml
Republica Moldova -
română -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
puregon solutie injectabila in cartus 600 ui/0,72 ml
merck sharp&dohme limited - follitropinum beta - solutie injectabila in cartus - 600 ui/0,72 ml
Uniunea Europeană -
română -
EMA (European Medicines Agency)
elonva
n.v. organon - corifollitropina alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - hormoni sexuali și modulatori ai sistemului genital, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).